2013 FIRST-HALF SALES

 
 
 
 

Longjumeau, July 23, 2013

 (in thousands of euros) H1-2012 published (including SBS) H1-2012 restated  (without SBS) H1-2013 % change
Sales 89 361 87 506 89 044+ 1,8%
including Pharmaceutical Synthesis 55 364 55 360 58 077 + 4,9%
including Fine Speciality Chemicals 33 997 32 146 30 967 - 3,7 %
(unaudited data)  

For information, the sale of SBS was finalised on March 20, 2013. SBS was presented on a specific line as "Net Result on discontinued operation" as of December 31, 2012.

For the first half of 2013, the consolidated sales of the PCAS Group are up by 1.8% compared to the same period of the preceding year, without SBS.

Pharmaceutical Synthesis
The Pharmaceutical Synthesis business has been continuing to develop in 2013 with growth of 4.9% relative to 2012.

Fine Specialty Chemicals
For the first half of 2013, Fine Specialty Chemicals are down (-3.7%) on 2012, affected by a sharp downturn in New Technologies business, while the Performance Chemicals business and, to a lesser extent, the Fragrance-Flavors-Cosmetics business have continued to grow.

The full six-monthly consolidated accounts will be examined by the Board of Directors on September 4, 2013.

 

About PCAS:

Founded in 1962, PCAS is an international fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS
designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.  PCAS also develops ranges of proprietary products based on intellectual property.
 
 

Financial communication : Vincent Touraille - Eric Financial communication : Vincent Touraille - Eric Moissenot | Tel +33 (0)1 69 09 77 85 | www.pcas.com:
http://www.pcas.com/

 
 
 
PCAS - 2013 First-Half Sales:
http://hugin.info/143512/R/1718146/571456.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: PCAS via Thomson Reuters ONE
HUG#1718146